Gofen & Glossberg LLC Spero Therapeutics, Inc. Transaction History
Gofen & Glossberg LLC
- $3.89 Billion
- Q4 2022
A detailed history of Gofen & Glossberg LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Gofen & Glossberg LLC holds 17,500 shares of SPRO stock, worth $35,875. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,500
Previous 17,500
-0.0%
Holding current value
$35,875
Previous $35,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SPRO
# of Institutions
49Shares Held
10.4MCall Options Held
0Put Options Held
186K-
Vanguard Group Inc Valley Forge, PA1.95MShares$4 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.62MShares$3.31 Million0.86% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$2.77 Million14.54% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$1.82 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny832KShares$1.71 Million0.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $71.9M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...